USPTO serial 88285675
PICOBIOTICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 23, 2022
- Examiner
- STIGLITZ, SUSAN R
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with PICOBIOTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Copenhagen, DK
Copenhagen, DK
Copenhagen, DK
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mark H. Tidman
Mark H. Tidman Baker & Hostetler LLP1050 Connecticut Avenue, NWWashington Square, Suite 1100Washington, DC 20036-5403Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations, namely, antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis; medical preparations, namely, antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis, and medical diagnostics; veterinary preparations, namely, antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis, and medical diagnostics; sanitary preparations for medical purposes; dietetic food and beverages adapted for medical or veterinary use; dietary supplements for human beings and animals; dietary supplements; antibiotic preparations; pharmaceutical preparations, namely, antiviral preparations; probiotic supplements; probiotic supplements for medical use; probiotic formulations for veterinary use, namely, antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis; probiotic formulations for medical use, namely, oral formulations, formulations for delivery to a microbiome in a human or animal, and formulations for delivery to skin, hair, mouth, gut, blood or a tissue, fluid or organ of a human or animal; microbiome modulators for veterinary purposes, namely, animal feed additives for use in animals feed to assist in digestion, growth or wellbeing; microbiome modulators for medical purposes, namely, as modulators of activity of pharmaceuticals in humans and animals; guided nuclease-based biocides; CRISPR-based biocides; pharmaceutical preparations for the treatment or prevention of disorders or diseases caused by bacteria | ACTIVE | — |
| 042 | Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological services, namely, scientific research, analysis and testing in the field of diseases and conditions associated with bacteria; industrial analysis and industrial research services; design and development of computer hardware and software; genetic microbiology and microbiome research; genetic engineering and services; design and development of hardware and software; clinical research in the field of microbes and anti-microbial medications; pharmaceutical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibiotics; research and development of guided nuclease-based biocides; research and development of CRISPR-based biocides; research and development of CRISPR technology for the treatment of microbial diseases; medical and scientific research, namely, conducting clinical trials for others; clinical research; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; bacteriological research; medical and scientific research in the field of microbes and anti-microbial medications; biological research; scientific and medical screening and assaying; chemical analysis; chemical research; Medical and health services relating to DNA, genetics and genetic pathogen testing, namely, providing medical and scientific research information in the fields of pharmaceuticals and medicine | ACTIVE | — |
| 044 | Medical services; diagnostic and prognostic medical services; veterinary services; medical analysis services relating to the treatment of persons in the nature of diagnostic and treatment counseling regarding the treatment of medical conditions and disease; pharmaceutical advice; medical and health services relating to DNA, genetics and genetic pathogen testing, namely, genetic testing for medical purposes; genetic counseling | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SNIPR Biome ApS
- Other trademarks owned by SNIPR Biome ApS
- Other trademarks owned by SNIPR Biome ApS
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named PICOBIOTICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 23, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 23, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 7, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 7, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 18, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 29, 2022 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Mar 30, 2022 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Mar 15, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 15, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 15, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 15, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 15, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 10, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 10, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 9, 2022 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Sep 10, 2021 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Sep 10, 2021 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Sep 10, 2021 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Aug 18, 2021 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Nov 23, 2020 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Nov 23, 2020 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Nov 23, 2020 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Nov 10, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 10, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 26, 2020 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Apr 27, 2020 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Apr 27, 2020 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Apr 27, 2020 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Apr 22, 2020 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Oct 15, 2019 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 15, 2019 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 15, 2019 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Oct 8, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 8, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 8, 2019 | ALIE | ASSIGNED TO LIE | — |
| Oct 2, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 16, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 16, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 16, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 15, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 24, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 5, 2019 | NWAP | NEW APPLICATION ENTERED | — |